Age | Informed Consent | Not pregnant
Item
subjects who are at least 18 years old and are willing and capable of providing informed consent. both men and non-pregnant women will be included.
boolean
C0001779 (UMLS CUI [1])
C0021430 (UMLS CUI [2])
C0232973 (UMLS CUI [3])
Liver carcinoma | Cytology | Histology | X-Ray Computed Tomography | Alpha one fetoprotein measurement
Item
hcc diagnosis documented prior to study entry by either cytology/histology, ct scan, and afp serum test higher or equal to 30 iu/ml.
boolean
C2239176 (UMLS CUI [1])
C1305671 (UMLS CUI [2])
C0344441 (UMLS CUI [3])
C0040405 (UMLS CUI [4])
C0201539 (UMLS CUI [5])
Females & males of reproductive potential Contraceptive methods
Item
all subjects with reproductive potential are advised to utilize effective contraception throughout the course of this study.
boolean
C4034483 (UMLS CUI [1,1])
C0700589 (UMLS CUI [1,2])
Health assessment questionnaire score | Informed Consent | Collection of blood specimen for laboratory procedure
Item
health score status at baseline. agreement to participate in the study and to give at least 3 samples of blood for lab tests.
boolean
C2960025 (UMLS CUI [1])
C0021430 (UMLS CUI [2])
C0005834 (UMLS CUI [3])
Home Availability | Address Availability
Item
readily available home or o other address where patient can be found. -
boolean
C0442519 (UMLS CUI [1,1])
C0470187 (UMLS CUI [1,2])
C1442065 (UMLS CUI [2,1])
C0470187 (UMLS CUI [2,2])
Investigational New Drug Intake Previous | Pregnancy | Breast Feeding
Item
subjects who might have already taken v5 in prior trials and have no baseline data. those who met inclusion criteria can be retrospectively enrolled. pregnant or breast-feeding women are excluded.
boolean
C0013230 (UMLS CUI [1,1])
C1512806 (UMLS CUI [1,2])
C0205156 (UMLS CUI [1,3])
C0032961 (UMLS CUI [2])
C0006147 (UMLS CUI [3])
Immunomodulation Other | systemic steroids | Immunoglobulin Therapy | Gamma globulin Intravenous | Immunoglobulins, Intravenous | Interferons | Interleukins | Pentoxifylline | Trental | Thalidomide | Filgrastim | sargramostim | Dinitrochlorobenzene | alpha-Thymosin | thymalfasin | Thymopentin | Inosine Pranobex | Isoprinosin | Ampligen | Ditiocarb Sodium | Imuthiol | Biological Response Modifiers | Liver carcinoma Vaccines | Study Subject Participation Status | Investigational New Drugs
Item
subjects who have taken other immunomodulatory therapies within 2 months prior to entry: systemic corticosteroids, immune globulin (iv gamma globulin, ivig), interferons, interleukins, pentoxifylline (trental), thalidomide, filgrastim (g-csf), sargramostim (gm-csf); dinitrochlorobenzene (dncb), thymosin alpha 1 (thymosin alpha), thymopentin, inosiplex (isoprinosine), polyribonucleoside (ampligen), ditiocarb sodium (imuthiol), any locally available immune modulators, and any other therapeutic or preventive hcc vaccine. subjects requiring concurrent participation in another experimental research treatment study, or who received an experimental agent within four weeks prior to study entry.
boolean
C1963758 (UMLS CUI [1,1])
C0205394 (UMLS CUI [1,2])
C2825233 (UMLS CUI [2])
C0021022 (UMLS CUI [3])
C0017007 (UMLS CUI [4,1])
C0348016 (UMLS CUI [4,2])
C0085297 (UMLS CUI [5])
C0021747 (UMLS CUI [6])
C0021764 (UMLS CUI [7])
C0030899 (UMLS CUI [8])
C0699487 (UMLS CUI [9])
C0039736 (UMLS CUI [10])
C0210630 (UMLS CUI [11])
C0216231 (UMLS CUI [12])
C0012460 (UMLS CUI [13])
C0368651 (UMLS CUI [14])
C0076612 (UMLS CUI [15])
C0080225 (UMLS CUI [16])
C0022230 (UMLS CUI [17])
C0795760 (UMLS CUI [18])
C0051764 (UMLS CUI [19])
C0700086 (UMLS CUI [20])
C0878291 (UMLS CUI [21])
C0005525 (UMLS CUI [22])
C2239176 (UMLS CUI [23,1])
C0042210 (UMLS CUI [23,2])
C2348568 (UMLS CUI [24])
C0013230 (UMLS CUI [25])
Heart Diseases | Epilepsy | Disease Life Threatening
Item
evidence of active or acute cardiac disease, epilepsy, or life-threatening diseases unrelated to hcc.
boolean
C0018799 (UMLS CUI [1])
C0014544 (UMLS CUI [2])
C0012634 (UMLS CUI [3,1])
C2826244 (UMLS CUI [3,2])
Medical condition Interferes with Study Protocol | Substance Use Disorders | Mental problem
Item
medical conditions such as active alcohol or substance abuse, or psychological issues that in the opinion of the local investigator would interfere with adherence to the requirements of this study.
boolean
C1699700 (UMLS CUI [1,1])
C0521102 (UMLS CUI [1,2])
C2348563 (UMLS CUI [1,3])
C0038586 (UMLS CUI [2])
C0848067 (UMLS CUI [3])